Fiorentino M - Search Results

1

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M. Loda M, et al. Among authors: fiorentino m. Nat Med. 1997 Feb;3(2):231-4. doi: 10.1038/nm0297-231. Nat Med. 1997. PMID: 9018245

2

Hepatitis C virus reinfection in orthotopic liver transplant patients with or without concomitant hepatitis B infection.

Loda M, Fiorentino M, Meckler J, Khettry U, Lewis D, Washburn K, Jenkins R, Mendoza AE, Samuelson J. Loda M, et al. Among authors: fiorentino m. Diagn Mol Pathol. 1996 Jun;5(2):81-7. doi: 10.1097/00019606-199606000-00002. Diagn Mol Pathol. 1996. PMID: 8727094

3

Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis.

Magi-Galluzzi C, Mishra R, Fiorentino M, Montironi R, Yao H, Capodieci P, Wishnow K, Kaplan I, Stork PJ, Loda M. Magi-Galluzzi C, et al. Among authors: fiorentino m. Lab Invest. 1997 Jan;76(1):37-51. Lab Invest. 1997. PMID: 9010448

4

Association between sucrase-isomaltase and p53 expression in colorectal cancer.

Lise M, Loda M, Fiorentino M, Mercurio AM, Summerhayes IC, Lavin PT, Jessup JM. Lise M, et al. Among authors: fiorentino m. Ann Surg Oncol. 1997 Mar;4(2):176-83. doi: 10.1007/BF02303802. Ann Surg Oncol. 1997. PMID: 9084856

5

Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma.

Fiorentino M, Altimari A, D'Errico A, Cukor B, Barozzi C, Loda M, Grigioni WF. Fiorentino M, et al. Clin Cancer Res. 2000 Oct;6(10):3966-72. Clin Cancer Res. 2000. PMID: 11051245

6

Differential requirement of mTOR in postmitotic tissues and tumorigenesis.

Nardella C, Carracedo A, Alimonti A, Hobbs RM, Clohessy JG, Chen Z, Egia A, Fornari A, Fiorentino M, Loda M, Kozma SC, Thomas G, Cordon-Cardo C, Pandolfi PP. Nardella C, et al. Among authors: fiorentino m. Sci Signal. 2009 Jan 27;2(55):ra2. doi: 10.1126/scisignal.2000189. Sci Signal. 2009. PMID: 19176516 Free PMC article.

7

Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.

Migita T, Ruiz S, Fornari A, Fiorentino M, Priolo C, Zadra G, Inazuka F, Grisanzio C, Palescandolo E, Shin E, Fiore C, Xie W, Kung AL, Febbo PG, Subramanian A, Mucci L, Ma J, Signoretti S, Stampfer M, Hahn WC, Finn S, Loda M. Migita T, et al. Among authors: fiorentino m. J Natl Cancer Inst. 2009 Apr 1;101(7):519-32. doi: 10.1093/jnci/djp030. Epub 2009 Mar 24. J Natl Cancer Inst. 2009. PMID: 19318631 Free PMC article.

8

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

Stark JR, Perner S, Stampfer MJ, Sinnott JA, Finn S, Eisenstein AS, Ma J, Fiorentino M, Kurth T, Loda M, Giovannucci EL, Rubin MA, Mucci LA. Stark JR, et al. Among authors: fiorentino m. J Clin Oncol. 2009 Jul 20;27(21):3459-64. doi: 10.1200/JCO.2008.20.4669. Epub 2009 May 11. J Clin Oncol. 2009. PMID: 19433685 Free PMC article.

9

The impact of Skp2 overexpression on recurrence-free survival following radical prostatectomy.

Nguyen PL, Lin DI, Lei J, Fiorentino M, Mueller E, Weinstein MH, Pagano M, Loda M. Nguyen PL, et al. Among authors: fiorentino m. Urol Oncol. 2011 May-Jun;29(3):302-8. doi: 10.1016/j.urolonc.2009.03.022. Epub 2009 May 17. Urol Oncol. 2011. PMID: 19450994 Free PMC article.

10

Blood and tissue biomarkers in prostate cancer: state of the art.

Fiorentino M, Capizzi E, Loda M. Fiorentino M, et al. Urol Clin North Am. 2010 Feb;37(1):131-41, Table of Contents. doi: 10.1016/j.ucl.2009.11.006. Urol Clin North Am. 2010. PMID: 20152526 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

721 results

Search Page